Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q3 EPS

Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Trump: everybody is fully aware that Iran will agree to have major weapons inspections in order to ensure "nuclear honesty" long into future
• Baldwin Insurance (BWIN) call put ratio 5.9 calls to 1 put with a focus on July 20 and 22.50 calls